Michail Ignatiadis
banner
mignatiadis.bsky.social
Michail Ignatiadis
@mignatiadis.bsky.social
Director Breast Medical Oncology, Jules Bordet Institute, Belgium
Focus on innovative, patient centric care and research
Reposted by Michail Ignatiadis
🚨 The final analysis of the phase 3 #ALEXANDRA/IMpassion030 study on adding atezolizumab to post-op chemo for high-risk early-stage #TNBC is out in @jama.com, contributing to a greater understanding of immunotherapy in #breastcancer👉 jamanetwork.com/journals/jam...
@mignatiadis.bsky.social
January 30, 2025 at 4:20 PM
Reposted by Michail Ignatiadis
The results of SONIA are out on @Nature. 1L use of palbo did not improve PFS over 2L use, but led to more AEs & costs. An evolving treatment landscape challenges its interpretation— yet it shows that sequencing trials are possible. Congrats to the authors! www.nature.com/articles/s41...
November 28, 2024 at 3:08 AM
Reposted by Michail Ignatiadis
Like ‘old Twitter’: The scientific community finds a new home on Bluesky
After recent changes to Elon Musk’s X, a gradual migration turns into a stampede

www.science.org/content/arti...
Like ‘old Twitter’: The scientific community finds a new home on Bluesky
After recent changes to Elon Musk’s X, a gradual migration turns into a stampede
www.science.org
November 23, 2024 at 4:19 PM
Reposted by Michail Ignatiadis
Institut Jules Bordet (part of the) medical oncology team dinner 🤗

@mignatiadis.bsky.social is already here 🦋 and we are lobbying for others to migrate!
November 23, 2024 at 3:22 PM